nodes	percent_of_prediction	percent_of_DWPC	metapath
Ifenprodil—HRH1—atherosclerosis	0.928	1	CbGaD
Ifenprodil—Cetirizine—HRH1—atherosclerosis	0.00175	0.213	CrCbGaD
Ifenprodil—Chlorcyclizine—HRH1—atherosclerosis	0.0016	0.194	CrCbGaD
Ifenprodil—Meclizine—HRH1—atherosclerosis	0.00147	0.178	CrCbGaD
Ifenprodil—Hydroxyzine—HRH1—atherosclerosis	0.00135	0.165	CrCbGaD
Ifenprodil—Diphenylpyraline—HRH1—atherosclerosis	0.00114	0.138	CrCbGaD
Ifenprodil—Cyclizine—HRH1—atherosclerosis	0.000915	0.111	CrCbGaD
Ifenprodil—EBP—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	0.000125	0.00197	CbGpPWpGaD
Ifenprodil—EBP—Metabolism—LIPC—atherosclerosis	0.000125	0.00196	CbGpPWpGaD
Ifenprodil—EBP—Metabolism—APOC3—atherosclerosis	0.000125	0.00195	CbGpPWpGaD
Ifenprodil—GRIN1—Developmental Biology—ADIPOQ—atherosclerosis	0.000124	0.00194	CbGpPWpGaD
Ifenprodil—EBP—Metabolism—LDLR—atherosclerosis	0.000124	0.00194	CbGpPWpGaD
Ifenprodil—GRIN1—Spinal Cord Injury—MAPK3—atherosclerosis	0.000124	0.00194	CbGpPWpGaD
Ifenprodil—GRIN1—SIDS Susceptibility Pathways—IL1B—atherosclerosis	0.000123	0.00194	CbGpPWpGaD
Ifenprodil—HRH1—Class A/1 (Rhodopsin-like receptors)—UTS2—atherosclerosis	0.000123	0.00193	CbGpPWpGaD
Ifenprodil—GRIN1—BDNF signaling pathway—NFKB1—atherosclerosis	0.000123	0.00193	CbGpPWpGaD
Ifenprodil—HRH1—IL-4 Signaling Pathway—NFKB1—atherosclerosis	0.000121	0.0019	CbGpPWpGaD
Ifenprodil—EBP—Metabolism—CETP—atherosclerosis	0.000121	0.0019	CbGpPWpGaD
Ifenprodil—GRIN2B—Developmental Biology—ADIPOQ—atherosclerosis	0.000121	0.0019	CbGpPWpGaD
Ifenprodil—GRIN1—BDNF signaling pathway—MAPK8—atherosclerosis	0.000121	0.00189	CbGpPWpGaD
Ifenprodil—GRIN1—Spinal Cord Injury—TGFB1—atherosclerosis	0.00012	0.00188	CbGpPWpGaD
Ifenprodil—GRIN2B—BDNF signaling pathway—NFKB1—atherosclerosis	0.00012	0.00188	CbGpPWpGaD
Ifenprodil—HRH1—Class A/1 (Rhodopsin-like receptors)—CX3CR1—atherosclerosis	0.000118	0.00185	CbGpPWpGaD
Ifenprodil—GRIN2B—BDNF signaling pathway—MAPK8—atherosclerosis	0.000118	0.00184	CbGpPWpGaD
Ifenprodil—KCNH2—Neuronal System—PRKCG—atherosclerosis	0.000118	0.00184	CbGpPWpGaD
Ifenprodil—EBP—Metabolism—SCARB1—atherosclerosis	0.000116	0.00182	CbGpPWpGaD
Ifenprodil—HRH1—Class A/1 (Rhodopsin-like receptors)—CX3CL1—atherosclerosis	0.000116	0.00181	CbGpPWpGaD
Ifenprodil—GRIN1—SIDS Susceptibility Pathways—NFKB1—atherosclerosis	0.000115	0.00181	CbGpPWpGaD
Ifenprodil—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—atherosclerosis	0.000115	0.00181	CbGpPWpGaD
Ifenprodil—EBP—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	0.000113	0.00177	CbGpPWpGaD
Ifenprodil—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—atherosclerosis	0.000112	0.00176	CbGpPWpGaD
Ifenprodil—GRIN1—Spinal Cord Injury—TNF—atherosclerosis	0.000112	0.00176	CbGpPWpGaD
Ifenprodil—GRIN1—BDNF signaling pathway—STAT3—atherosclerosis	0.00011	0.00173	CbGpPWpGaD
Ifenprodil—HRH1—G alpha (q) signalling events—KNG1—atherosclerosis	0.00011	0.00173	CbGpPWpGaD
Ifenprodil—HRH1—Class A/1 (Rhodopsin-like receptors)—CNR2—atherosclerosis	0.00011	0.00172	CbGpPWpGaD
Ifenprodil—HRH1—G alpha (q) signalling events—AGTR1—atherosclerosis	0.000109	0.00172	CbGpPWpGaD
Ifenprodil—EBP—Metabolism—HMGCR—atherosclerosis	0.000109	0.00171	CbGpPWpGaD
Ifenprodil—HRH1—IL-4 Signaling Pathway—STAT3—atherosclerosis	0.000109	0.00171	CbGpPWpGaD
Ifenprodil—GRIN2B—BDNF signaling pathway—STAT3—atherosclerosis	0.000108	0.00169	CbGpPWpGaD
Ifenprodil—KCNH2—SIDS Susceptibility Pathways—CXCL8—atherosclerosis	0.000107	0.00168	CbGpPWpGaD
Ifenprodil—GRIN1—BDNF signaling pathway—MAPK3—atherosclerosis	0.000105	0.00165	CbGpPWpGaD
Ifenprodil—HRH1—GPCR ligand binding—CCL4—atherosclerosis	0.000105	0.00165	CbGpPWpGaD
Ifenprodil—GRIN1—SIDS Susceptibility Pathways—VEGFA—atherosclerosis	0.000105	0.00164	CbGpPWpGaD
Ifenprodil—HRH1—IL-4 Signaling Pathway—MAPK3—atherosclerosis	0.000104	0.00163	CbGpPWpGaD
Ifenprodil—KCNH2—SIDS Susceptibility Pathways—IL1B—atherosclerosis	0.000103	0.00161	CbGpPWpGaD
Ifenprodil—GRIN2B—BDNF signaling pathway—MAPK3—atherosclerosis	0.000103	0.00161	CbGpPWpGaD
Ifenprodil—HRH1—GPCRs, Class A Rhodopsin-like—EDNRA—atherosclerosis	9.95e-05	0.00156	CbGpPWpGaD
Ifenprodil—HRH1—GPCRs, Class A Rhodopsin-like—CCR2—atherosclerosis	9.95e-05	0.00156	CbGpPWpGaD
Ifenprodil—EBP—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	9.86e-05	0.00155	CbGpPWpGaD
Ifenprodil—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—KNG1—atherosclerosis	9.85e-05	0.00154	CbGpPWpGaD
Ifenprodil—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—atherosclerosis	9.79e-05	0.00153	CbGpPWpGaD
Ifenprodil—EBP—Metabolism—ABCA1—atherosclerosis	9.74e-05	0.00153	CbGpPWpGaD
Ifenprodil—KCNH2—SIDS Susceptibility Pathways—NFKB1—atherosclerosis	9.59e-05	0.0015	CbGpPWpGaD
Ifenprodil—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL3—atherosclerosis	9.43e-05	0.00148	CbGpPWpGaD
Ifenprodil—HRH1—GPCR ligand binding—UTS2—atherosclerosis	9.37e-05	0.00147	CbGpPWpGaD
Ifenprodil—HRH1—G alpha (q) signalling events—EDN1—atherosclerosis	9.28e-05	0.00145	CbGpPWpGaD
Ifenprodil—GRIN1—Developmental Biology—LPL—atherosclerosis	9.19e-05	0.00144	CbGpPWpGaD
Ifenprodil—GRIN1—Spinal Cord Injury—IL6—atherosclerosis	9.04e-05	0.00142	CbGpPWpGaD
Ifenprodil—HRH1—GPCR ligand binding—CX3CR1—atherosclerosis	8.98e-05	0.00141	CbGpPWpGaD
Ifenprodil—HRH1—GPCR ligand binding—CASR—atherosclerosis	8.98e-05	0.00141	CbGpPWpGaD
Ifenprodil—GRIN1—SIDS Susceptibility Pathways—TNF—atherosclerosis	8.96e-05	0.0014	CbGpPWpGaD
Ifenprodil—GRIN2B—Developmental Biology—LPL—atherosclerosis	8.96e-05	0.0014	CbGpPWpGaD
Ifenprodil—HRH1—GPCR ligand binding—CX3CL1—atherosclerosis	8.81e-05	0.00138	CbGpPWpGaD
Ifenprodil—GRIN1—Developmental Biology—CD36—atherosclerosis	8.73e-05	0.00137	CbGpPWpGaD
Ifenprodil—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—atherosclerosis	8.72e-05	0.00137	CbGpPWpGaD
Ifenprodil—KCNH2—SIDS Susceptibility Pathways—VEGFA—atherosclerosis	8.71e-05	0.00137	CbGpPWpGaD
Ifenprodil—GRIN1—Axon guidance—MMP2—atherosclerosis	8.63e-05	0.00135	CbGpPWpGaD
Ifenprodil—HRH1—Class A/1 (Rhodopsin-like receptors)—EDNRA—atherosclerosis	8.52e-05	0.00134	CbGpPWpGaD
Ifenprodil—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR2—atherosclerosis	8.52e-05	0.00134	CbGpPWpGaD
Ifenprodil—GRIN2B—Developmental Biology—CD36—atherosclerosis	8.51e-05	0.00133	CbGpPWpGaD
Ifenprodil—HRH1—GPCRs, Class A Rhodopsin-like—AGTR1—atherosclerosis	8.46e-05	0.00133	CbGpPWpGaD
Ifenprodil—GRIN2B—Axon guidance—MMP2—atherosclerosis	8.41e-05	0.00132	CbGpPWpGaD
Ifenprodil—EBP—Metabolism—HMOX1—atherosclerosis	8.36e-05	0.00131	CbGpPWpGaD
Ifenprodil—HRH1—GPCR ligand binding—CNR2—atherosclerosis	8.35e-05	0.00131	CbGpPWpGaD
Ifenprodil—HRH1—Class A/1 (Rhodopsin-like receptors)—GHRL—atherosclerosis	8.31e-05	0.0013	CbGpPWpGaD
Ifenprodil—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—atherosclerosis	8.3e-05	0.0013	CbGpPWpGaD
Ifenprodil—GRIN1—Developmental Biology—PPARA—atherosclerosis	8.12e-05	0.00127	CbGpPWpGaD
Ifenprodil—EBP—Metabolism—APOB—atherosclerosis	8.01e-05	0.00126	CbGpPWpGaD
Ifenprodil—GRIN2B—Developmental Biology—PPARA—atherosclerosis	7.91e-05	0.00124	CbGpPWpGaD
Ifenprodil—EBP—Metabolism—GSTM1—atherosclerosis	7.79e-05	0.00122	CbGpPWpGaD
Ifenprodil—HRH1—G alpha (q) signalling events—AGT—atherosclerosis	7.7e-05	0.00121	CbGpPWpGaD
Ifenprodil—GRIN1—Developmental Biology—LEP—atherosclerosis	7.7e-05	0.00121	CbGpPWpGaD
Ifenprodil—EBP—Metabolism—LPL—atherosclerosis	7.65e-05	0.0012	CbGpPWpGaD
Ifenprodil—GRIN2B—Developmental Biology—LEP—atherosclerosis	7.51e-05	0.00118	CbGpPWpGaD
Ifenprodil—KCNH2—SIDS Susceptibility Pathways—TNF—atherosclerosis	7.46e-05	0.00117	CbGpPWpGaD
Ifenprodil—EBP—Metabolism—GPX1—atherosclerosis	7.46e-05	0.00117	CbGpPWpGaD
Ifenprodil—HRH1—Class A/1 (Rhodopsin-like receptors)—KNG1—atherosclerosis	7.29e-05	0.00114	CbGpPWpGaD
Ifenprodil—EBP—Metabolism—CD36—atherosclerosis	7.27e-05	0.00114	CbGpPWpGaD
Ifenprodil—HRH1—Class A/1 (Rhodopsin-like receptors)—AGTR1—atherosclerosis	7.25e-05	0.00114	CbGpPWpGaD
Ifenprodil—GRIN1—SIDS Susceptibility Pathways—IL6—atherosclerosis	7.23e-05	0.00113	CbGpPWpGaD
Ifenprodil—HRH1—GPCR ligand binding—CCL3—atherosclerosis	7.18e-05	0.00113	CbGpPWpGaD
Ifenprodil—HRH1—G alpha (q) signalling events—F2—atherosclerosis	7.12e-05	0.00112	CbGpPWpGaD
Ifenprodil—GRIN1—BDNF signaling pathway—AKT1—atherosclerosis	7.11e-05	0.00111	CbGpPWpGaD
Ifenprodil—HRH1—IL-4 Signaling Pathway—AKT1—atherosclerosis	7.02e-05	0.0011	CbGpPWpGaD
Ifenprodil—GRIN2B—BDNF signaling pathway—AKT1—atherosclerosis	6.93e-05	0.00109	CbGpPWpGaD
Ifenprodil—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—atherosclerosis	6.89e-05	0.00108	CbGpPWpGaD
Ifenprodil—EBP—Metabolism—MTHFR—atherosclerosis	6.88e-05	0.00108	CbGpPWpGaD
Ifenprodil—EBP—Metabolism—PPARA—atherosclerosis	6.75e-05	0.00106	CbGpPWpGaD
Ifenprodil—GRIN1—Developmental Biology—PPARG—atherosclerosis	6.71e-05	0.00105	CbGpPWpGaD
Ifenprodil—GRIN1—Developmental Biology—INS—atherosclerosis	6.58e-05	0.00103	CbGpPWpGaD
Ifenprodil—EBP—Metabolism—AGT—atherosclerosis	6.54e-05	0.00103	CbGpPWpGaD
Ifenprodil—GRIN2B—Developmental Biology—PPARG—atherosclerosis	6.54e-05	0.00103	CbGpPWpGaD
Ifenprodil—HRH1—GPCR ligand binding—CCR2—atherosclerosis	6.49e-05	0.00102	CbGpPWpGaD
Ifenprodil—HRH1—GPCR ligand binding—EDNRA—atherosclerosis	6.49e-05	0.00102	CbGpPWpGaD
Ifenprodil—GRIN1—Axon guidance—MMP9—atherosclerosis	6.49e-05	0.00102	CbGpPWpGaD
Ifenprodil—GRIN2B—Developmental Biology—INS—atherosclerosis	6.41e-05	0.00101	CbGpPWpGaD
Ifenprodil—EBP—Metabolism—APOE—atherosclerosis	6.41e-05	0.001	CbGpPWpGaD
Ifenprodil—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—F2—atherosclerosis	6.36e-05	0.000998	CbGpPWpGaD
Ifenprodil—EBP—Metabolism—CAV1—atherosclerosis	6.35e-05	0.000996	CbGpPWpGaD
Ifenprodil—EBP—Metabolism—APOA1—atherosclerosis	6.34e-05	0.000993	CbGpPWpGaD
Ifenprodil—HRH1—GPCR ligand binding—GHRL—atherosclerosis	6.33e-05	0.000992	CbGpPWpGaD
Ifenprodil—GRIN2B—Axon guidance—MMP9—atherosclerosis	6.32e-05	0.000992	CbGpPWpGaD
Ifenprodil—GRIN1—Developmental Biology—MMP2—atherosclerosis	6.16e-05	0.000966	CbGpPWpGaD
Ifenprodil—HRH1—Class A/1 (Rhodopsin-like receptors)—EDN1—atherosclerosis	6.15e-05	0.000964	CbGpPWpGaD
Ifenprodil—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL5—atherosclerosis	6.1e-05	0.000956	CbGpPWpGaD
Ifenprodil—KCNH2—SIDS Susceptibility Pathways—IL6—atherosclerosis	6.02e-05	0.000944	CbGpPWpGaD
Ifenprodil—GRIN2B—Developmental Biology—MMP2—atherosclerosis	6e-05	0.000941	CbGpPWpGaD
Ifenprodil—GRIN1—Axon guidance—VEGFA—atherosclerosis	5.82e-05	0.000913	CbGpPWpGaD
Ifenprodil—EBP—Metabolism—PIK3CG—atherosclerosis	5.78e-05	0.000907	CbGpPWpGaD
Ifenprodil—GRIN2B—Axon guidance—VEGFA—atherosclerosis	5.68e-05	0.00089	CbGpPWpGaD
Ifenprodil—EBP—Metabolism—PPARG—atherosclerosis	5.58e-05	0.000875	CbGpPWpGaD
Ifenprodil—HRH1—GPCR ligand binding—KNG1—atherosclerosis	5.55e-05	0.000871	CbGpPWpGaD
Ifenprodil—HRH1—GPCR ligand binding—AGTR1—atherosclerosis	5.52e-05	0.000865	CbGpPWpGaD
Ifenprodil—GRIN1—Axon guidance—MAPK3—atherosclerosis	5.51e-05	0.000864	CbGpPWpGaD
Ifenprodil—EBP—Metabolism—INS—atherosclerosis	5.48e-05	0.000859	CbGpPWpGaD
Ifenprodil—HRH1—Signaling by GPCR—CCL4—atherosclerosis	5.39e-05	0.000846	CbGpPWpGaD
Ifenprodil—GRIN2B—Axon guidance—MAPK3—atherosclerosis	5.37e-05	0.000842	CbGpPWpGaD
Ifenprodil—HRH1—GPCR downstream signaling—UTS2—atherosclerosis	5.29e-05	0.00083	CbGpPWpGaD
Ifenprodil—HRH1—Class A/1 (Rhodopsin-like receptors)—AGT—atherosclerosis	5.1e-05	0.0008	CbGpPWpGaD
Ifenprodil—HRH1—GPCR downstream signaling—CASR—atherosclerosis	5.07e-05	0.000796	CbGpPWpGaD
Ifenprodil—EBP—Metabolism—ALB—atherosclerosis	5.02e-05	0.000787	CbGpPWpGaD
Ifenprodil—HRH1—Signaling by GPCR—UTS2—atherosclerosis	4.81e-05	0.000754	CbGpPWpGaD
Ifenprodil—EBP—Metabolism—NOS3—atherosclerosis	4.8e-05	0.000753	CbGpPWpGaD
Ifenprodil—HRH1—GPCR downstream signaling—CNR2—atherosclerosis	4.72e-05	0.00074	CbGpPWpGaD
Ifenprodil—HRH1—Class A/1 (Rhodopsin-like receptors)—F2—atherosclerosis	4.71e-05	0.000739	CbGpPWpGaD
Ifenprodil—HRH1—GPCR ligand binding—EDN1—atherosclerosis	4.68e-05	0.000734	CbGpPWpGaD
Ifenprodil—HRH1—GPCR ligand binding—CCL5—atherosclerosis	4.64e-05	0.000728	CbGpPWpGaD
Ifenprodil—GRIN1—Developmental Biology—MMP9—atherosclerosis	4.63e-05	0.000726	CbGpPWpGaD
Ifenprodil—HRH1—Signaling by GPCR—CX3CR1—atherosclerosis	4.61e-05	0.000723	CbGpPWpGaD
Ifenprodil—HRH1—Signaling by GPCR—CASR—atherosclerosis	4.61e-05	0.000723	CbGpPWpGaD
Ifenprodil—GRIN1—Developmental Biology—NFKB1—atherosclerosis	4.58e-05	0.000718	CbGpPWpGaD
Ifenprodil—HRH1—Signaling by GPCR—CX3CL1—atherosclerosis	4.52e-05	0.000709	CbGpPWpGaD
Ifenprodil—GRIN2B—Developmental Biology—MMP9—atherosclerosis	4.51e-05	0.000708	CbGpPWpGaD
Ifenprodil—GRIN2B—Developmental Biology—NFKB1—atherosclerosis	4.46e-05	0.0007	CbGpPWpGaD
Ifenprodil—EBP—Metabolism—PTGS2—atherosclerosis	4.39e-05	0.000689	CbGpPWpGaD
Ifenprodil—HRH1—Signaling by GPCR—CNR2—atherosclerosis	4.28e-05	0.000672	CbGpPWpGaD
Ifenprodil—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL2—atherosclerosis	4.2e-05	0.000659	CbGpPWpGaD
Ifenprodil—GRIN1—Developmental Biology—VEGFA—atherosclerosis	4.16e-05	0.000652	CbGpPWpGaD
Ifenprodil—GRIN1—Developmental Biology—STAT3—atherosclerosis	4.12e-05	0.000645	CbGpPWpGaD
Ifenprodil—GRIN2B—Developmental Biology—VEGFA—atherosclerosis	4.05e-05	0.000635	CbGpPWpGaD
Ifenprodil—GRIN1—Axon guidance—IL6—atherosclerosis	4.03e-05	0.000632	CbGpPWpGaD
Ifenprodil—GRIN2B—Developmental Biology—STAT3—atherosclerosis	4.01e-05	0.000629	CbGpPWpGaD
Ifenprodil—GRIN1—Developmental Biology—MAPK3—atherosclerosis	3.93e-05	0.000617	CbGpPWpGaD
Ifenprodil—GRIN2B—Axon guidance—IL6—atherosclerosis	3.93e-05	0.000616	CbGpPWpGaD
Ifenprodil—HRH1—GPCR ligand binding—AGT—atherosclerosis	3.88e-05	0.000609	CbGpPWpGaD
Ifenprodil—GRIN2B—Developmental Biology—MAPK3—atherosclerosis	3.83e-05	0.000601	CbGpPWpGaD
Ifenprodil—GRIN1—Developmental Biology—TGFB1—atherosclerosis	3.82e-05	0.000598	CbGpPWpGaD
Ifenprodil—GRIN2B—Developmental Biology—TGFB1—atherosclerosis	3.72e-05	0.000583	CbGpPWpGaD
Ifenprodil—HRH1—Signaling by GPCR—CCL3—atherosclerosis	3.68e-05	0.000578	CbGpPWpGaD
Ifenprodil—HRH1—GPCR downstream signaling—CCR2—atherosclerosis	3.67e-05	0.000575	CbGpPWpGaD
Ifenprodil—HRH1—GPCR downstream signaling—EDNRA—atherosclerosis	3.67e-05	0.000575	CbGpPWpGaD
Ifenprodil—HRH1—GPCR ligand binding—F2—atherosclerosis	3.59e-05	0.000563	CbGpPWpGaD
Ifenprodil—HRH1—GPCR downstream signaling—GHRL—atherosclerosis	3.58e-05	0.000561	CbGpPWpGaD
Ifenprodil—GRIN1—Developmental Biology—TNF—atherosclerosis	3.56e-05	0.000559	CbGpPWpGaD
Ifenprodil—GRIN2B—Developmental Biology—TNF—atherosclerosis	3.47e-05	0.000545	CbGpPWpGaD
Ifenprodil—HRH1—Signaling Pathways—APOA4—atherosclerosis	3.46e-05	0.000542	CbGpPWpGaD
Ifenprodil—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—atherosclerosis	3.45e-05	0.00054	CbGpPWpGaD
Ifenprodil—HRH1—Signaling by GPCR—CCR2—atherosclerosis	3.33e-05	0.000522	CbGpPWpGaD
Ifenprodil—HRH1—Signaling by GPCR—EDNRA—atherosclerosis	3.33e-05	0.000522	CbGpPWpGaD
Ifenprodil—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	3.32e-05	0.000521	CbGpPWpGaD
Ifenprodil—HRH1—Signaling by GPCR—GHRL—atherosclerosis	3.25e-05	0.000509	CbGpPWpGaD
Ifenprodil—HRH1—GPCR ligand binding—CCL2—atherosclerosis	3.2e-05	0.000502	CbGpPWpGaD
Ifenprodil—HRH1—Signaling Pathways—CCL4—atherosclerosis	3.19e-05	0.000499	CbGpPWpGaD
Ifenprodil—HRH1—GPCR downstream signaling—KNG1—atherosclerosis	3.14e-05	0.000492	CbGpPWpGaD
Ifenprodil—HRH1—GPCR downstream signaling—AGTR1—atherosclerosis	3.12e-05	0.000489	CbGpPWpGaD
Ifenprodil—HRH1—Signaling Pathways—APOA2—atherosclerosis	2.98e-05	0.000467	CbGpPWpGaD
Ifenprodil—GRIN1—Developmental Biology—IL6—atherosclerosis	2.87e-05	0.000451	CbGpPWpGaD
Ifenprodil—HRH1—Signaling by GPCR—KNG1—atherosclerosis	2.85e-05	0.000447	CbGpPWpGaD
Ifenprodil—HRH1—Signaling Pathways—UTS2—atherosclerosis	2.84e-05	0.000445	CbGpPWpGaD
Ifenprodil—HRH1—Signaling by GPCR—AGTR1—atherosclerosis	2.83e-05	0.000444	CbGpPWpGaD
Ifenprodil—GRIN2B—Developmental Biology—IL6—atherosclerosis	2.8e-05	0.000439	CbGpPWpGaD
Ifenprodil—HRH1—Signaling Pathways—CX3CR1—atherosclerosis	2.72e-05	0.000427	CbGpPWpGaD
Ifenprodil—HRH1—Signaling Pathways—CASR—atherosclerosis	2.72e-05	0.000427	CbGpPWpGaD
Ifenprodil—HRH1—Signaling Pathways—CX3CL1—atherosclerosis	2.67e-05	0.000419	CbGpPWpGaD
Ifenprodil—GRIN1—Developmental Biology—AKT1—atherosclerosis	2.65e-05	0.000416	CbGpPWpGaD
Ifenprodil—HRH1—GPCR downstream signaling—EDN1—atherosclerosis	2.64e-05	0.000415	CbGpPWpGaD
Ifenprodil—HRH1—GPCR downstream signaling—CCL5—atherosclerosis	2.62e-05	0.000411	CbGpPWpGaD
Ifenprodil—GRIN2B—Developmental Biology—AKT1—atherosclerosis	2.59e-05	0.000405	CbGpPWpGaD
Ifenprodil—HRH1—Signaling Pathways—CNR2—atherosclerosis	2.53e-05	0.000397	CbGpPWpGaD
Ifenprodil—HRH1—GPCR ligand binding—CXCL8—atherosclerosis	2.53e-05	0.000397	CbGpPWpGaD
Ifenprodil—HRH1—Signaling by GPCR—MMP3—atherosclerosis	2.52e-05	0.000396	CbGpPWpGaD
Ifenprodil—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atherosclerosis	2.52e-05	0.000395	CbGpPWpGaD
Ifenprodil—HRH1—GPCR downstream signaling—PRKCG—atherosclerosis	2.49e-05	0.000391	CbGpPWpGaD
Ifenprodil—HRH1—Signaling by GPCR—EDN1—atherosclerosis	2.4e-05	0.000377	CbGpPWpGaD
Ifenprodil—HRH1—Signaling by GPCR—CCL5—atherosclerosis	2.38e-05	0.000374	CbGpPWpGaD
Ifenprodil—HRH1—Signaling by GPCR—PRKCG—atherosclerosis	2.27e-05	0.000355	CbGpPWpGaD
Ifenprodil—HRH1—Signaling Pathways—VWF—atherosclerosis	2.26e-05	0.000354	CbGpPWpGaD
Ifenprodil—HRH1—Signaling Pathways—APOC3—atherosclerosis	2.24e-05	0.000351	CbGpPWpGaD
Ifenprodil—HRH1—Signaling Pathways—LDLR—atherosclerosis	2.23e-05	0.000349	CbGpPWpGaD
Ifenprodil—EBP—Metabolism—AKT1—atherosclerosis	2.21e-05	0.000346	CbGpPWpGaD
Ifenprodil—HRH1—GPCR downstream signaling—AGT—atherosclerosis	2.2e-05	0.000344	CbGpPWpGaD
Ifenprodil—HRH1—Signaling Pathways—CCL3—atherosclerosis	2.18e-05	0.000341	CbGpPWpGaD
Ifenprodil—HRH1—Signaling Pathways—NCF1—atherosclerosis	2.08e-05	0.000327	CbGpPWpGaD
Ifenprodil—HRH1—GPCR downstream signaling—F2—atherosclerosis	2.03e-05	0.000318	CbGpPWpGaD
Ifenprodil—HRH1—Signaling by GPCR—AGT—atherosclerosis	1.99e-05	0.000313	CbGpPWpGaD
Ifenprodil—HRH1—Signaling Pathways—EDNRA—atherosclerosis	1.97e-05	0.000309	CbGpPWpGaD
Ifenprodil—HRH1—Signaling Pathways—CCR2—atherosclerosis	1.97e-05	0.000309	CbGpPWpGaD
Ifenprodil—HRH1—Signaling Pathways—CYBA—atherosclerosis	1.96e-05	0.000307	CbGpPWpGaD
Ifenprodil—HRH1—GPCR downstream signaling—PIK3CG—atherosclerosis	1.94e-05	0.000304	CbGpPWpGaD
Ifenprodil—HRH1—Signaling Pathways—PARP1—atherosclerosis	1.92e-05	0.000301	CbGpPWpGaD
Ifenprodil—HRH1—Signaling Pathways—GHRL—atherosclerosis	1.92e-05	0.000301	CbGpPWpGaD
Ifenprodil—HRH1—Signaling Pathways—PLAT—atherosclerosis	1.92e-05	0.000301	CbGpPWpGaD
Ifenprodil—HRH1—Signaling by GPCR—F2—atherosclerosis	1.84e-05	0.000289	CbGpPWpGaD
Ifenprodil—HRH1—Signaling by GPCR—PIK3CG—atherosclerosis	1.76e-05	0.000276	CbGpPWpGaD
Ifenprodil—HRH1—Signaling Pathways—KNG1—atherosclerosis	1.68e-05	0.000264	CbGpPWpGaD
Ifenprodil—HRH1—Signaling Pathways—AGTR1—atherosclerosis	1.67e-05	0.000262	CbGpPWpGaD
Ifenprodil—HRH1—Signaling by GPCR—CCL2—atherosclerosis	1.64e-05	0.000257	CbGpPWpGaD
Ifenprodil—HRH1—Signaling Pathways—PLG—atherosclerosis	1.63e-05	0.000256	CbGpPWpGaD
Ifenprodil—HRH1—Signaling Pathways—SOCS3—atherosclerosis	1.54e-05	0.000242	CbGpPWpGaD
Ifenprodil—HRH1—Signaling Pathways—MMP3—atherosclerosis	1.49e-05	0.000234	CbGpPWpGaD
Ifenprodil—HRH1—Signaling Pathways—IGF2—atherosclerosis	1.48e-05	0.000233	CbGpPWpGaD
Ifenprodil—HRH1—Signaling Pathways—APOB—atherosclerosis	1.44e-05	0.000226	CbGpPWpGaD
Ifenprodil—HRH1—GPCR downstream signaling—CXCL8—atherosclerosis	1.43e-05	0.000224	CbGpPWpGaD
Ifenprodil—HRH1—Signaling Pathways—EDN1—atherosclerosis	1.42e-05	0.000222	CbGpPWpGaD
Ifenprodil—HRH1—Signaling Pathways—CCL5—atherosclerosis	1.41e-05	0.000221	CbGpPWpGaD
Ifenprodil—HRH1—Signaling Pathways—LPL—atherosclerosis	1.38e-05	0.000216	CbGpPWpGaD
Ifenprodil—HRH1—Signaling Pathways—PRKCG—atherosclerosis	1.34e-05	0.00021	CbGpPWpGaD
Ifenprodil—HRH1—Signaling Pathways—SPP1—atherosclerosis	1.3e-05	0.000204	CbGpPWpGaD
Ifenprodil—HRH1—Signaling by GPCR—CXCL8—atherosclerosis	1.3e-05	0.000204	CbGpPWpGaD
Ifenprodil—HRH1—Signaling Pathways—PDGFB—atherosclerosis	1.21e-05	0.000189	CbGpPWpGaD
Ifenprodil—HRH1—Signaling Pathways—AGT—atherosclerosis	1.18e-05	0.000185	CbGpPWpGaD
Ifenprodil—HRH1—Signaling Pathways—LEP—atherosclerosis	1.15e-05	0.000181	CbGpPWpGaD
Ifenprodil—HRH1—Signaling Pathways—APOE—atherosclerosis	1.15e-05	0.000181	CbGpPWpGaD
Ifenprodil—HRH1—Signaling Pathways—CAV1—atherosclerosis	1.14e-05	0.000179	CbGpPWpGaD
Ifenprodil—HRH1—Signaling Pathways—APOA1—atherosclerosis	1.14e-05	0.000179	CbGpPWpGaD
Ifenprodil—HRH1—Signaling Pathways—ESR1—atherosclerosis	1.1e-05	0.000173	CbGpPWpGaD
Ifenprodil—HRH1—Signaling Pathways—F2—atherosclerosis	1.09e-05	0.000171	CbGpPWpGaD
Ifenprodil—HRH1—Signaling Pathways—PIK3CG—atherosclerosis	1.04e-05	0.000163	CbGpPWpGaD
Ifenprodil—HRH1—Signaling by GPCR—MAPK3—atherosclerosis	9.97e-06	0.000156	CbGpPWpGaD
Ifenprodil—HRH1—Signaling Pathways—INS—atherosclerosis	9.86e-06	0.000155	CbGpPWpGaD
Ifenprodil—HRH1—Signaling Pathways—CCL2—atherosclerosis	9.7e-06	0.000152	CbGpPWpGaD
Ifenprodil—HRH1—Signaling Pathways—IGF1—atherosclerosis	9.53e-06	0.000149	CbGpPWpGaD
Ifenprodil—HRH1—Signaling Pathways—SERPINE1—atherosclerosis	9.05e-06	0.000142	CbGpPWpGaD
Ifenprodil—HRH1—Signaling Pathways—NOS3—atherosclerosis	8.64e-06	0.000136	CbGpPWpGaD
Ifenprodil—HRH1—Signaling Pathways—CXCL8—atherosclerosis	7.67e-06	0.00012	CbGpPWpGaD
Ifenprodil—HRH1—GPCR downstream signaling—AKT1—atherosclerosis	7.41e-06	0.000116	CbGpPWpGaD
Ifenprodil—HRH1—Signaling by GPCR—IL6—atherosclerosis	7.29e-06	0.000114	CbGpPWpGaD
Ifenprodil—HRH1—Signaling Pathways—MMP9—atherosclerosis	6.93e-06	0.000109	CbGpPWpGaD
Ifenprodil—HRH1—Signaling Pathways—NFKB1—atherosclerosis	6.86e-06	0.000108	CbGpPWpGaD
Ifenprodil—HRH1—Signaling Pathways—MAPK8—atherosclerosis	6.74e-06	0.000106	CbGpPWpGaD
Ifenprodil—HRH1—Signaling by GPCR—AKT1—atherosclerosis	6.73e-06	0.000105	CbGpPWpGaD
Ifenprodil—HRH1—Signaling Pathways—VEGFA—atherosclerosis	6.23e-06	9.76e-05	CbGpPWpGaD
Ifenprodil—HRH1—Signaling Pathways—STAT3—atherosclerosis	6.17e-06	9.67e-05	CbGpPWpGaD
Ifenprodil—HRH1—Signaling Pathways—MAPK3—atherosclerosis	5.89e-06	9.24e-05	CbGpPWpGaD
Ifenprodil—HRH1—Signaling Pathways—TGFB1—atherosclerosis	5.72e-06	8.96e-05	CbGpPWpGaD
Ifenprodil—HRH1—Signaling Pathways—IL6—atherosclerosis	4.31e-06	6.75e-05	CbGpPWpGaD
Ifenprodil—HRH1—Signaling Pathways—AKT1—atherosclerosis	3.97e-06	6.23e-05	CbGpPWpGaD
